公开(公告)号：US09750267B2

公开(公告)日：2017-09-05

申请号：US12256101

申请日：2008-10-22

Applicant: Basant K. Dwivedi

Inventor： Basant K. Dwivedi

IPC: A23C9/12 ,  A23C9/133 ,  A23L1/03 ,  A23P1/08 ,  A23G3/54 ,  A23L1/064 ,  A23G3/36 ,  A23G3/48 ,  A23P20/25 ,  A23L19/00 ,  A23L33/135

CPC classification number: A23G3/54 ,  A23G3/366 ,  A23G3/48 ,  A23L19/09 ,  A23L33/135 ,  A23P20/25

Abstract: A fruit snack with probiotics that is stable at room temperature is manufactured by combining various ingredients including fruit juices/purees to produce a slurry and cooking the slurry to produce a center that contains a high moisture content. The fruit snack center is covered with a barrier layer which in turn is covered by an outer layer that contains heat sensitive ingredients, such as probiotic cultures. The barrier layer substantially prevents migration of moisture from the center to the outer layer, and the fruit snack is cooled prior to applying the outer layer to minimize damage/harm to the heat sensitive ingredients. In addition to including probiotic cultures and being stable at room temperature, the fruit snack has other desirable characteristics including a chewy soft texture and fruit-flavorings, and may be manufactured using traditional processes.

公开(公告)号：US09516888B2

公开(公告)日：2016-12-13

申请号：US13375860

申请日：2010-04-23

Applicant: Toru Katase ,  Yukiko Hoshi ,  Miho Nagaya ,  Shotaro Yamaguchi ,  Masashi Minoda ,  Kazuhiro Nakanishi

Inventor： Toru Katase ,  Yukiko Hoshi ,  Miho Nagaya ,  Shotaro Yamaguchi ,  Masashi Minoda ,  Kazuhiro Nakanishi

IPC: C12P21/02 ,  A23C9/12 ,  A23L1/03 ,  A61K38/47 ,  C12N9/38

CPC classification number: A23C9/1206 ,  A23L29/06 ,  A61K38/47 ,  C12N9/2471 ,  C12Y302/01023

Abstract: Disclosed is a novel β-galactosidase. Specifically disclosed are a β-galactosidase derived from Bacillus circulans and a gene for the β-galactosidase. The β-galactosidase can be used, for example, in the production of milk, dairy products, fermented dairy products, galacto-oligosaccharides or supplements for foods.

Abstract translation: 公开了一种新型β-半乳糖苷酶。 具体公开了衍生自环状芽孢杆菌的β-半乳糖苷酶和β-半乳糖苷酶的基因。 β-半乳糖苷酶可用于例如生产牛奶，乳制品，发酵乳制品，低聚半乳糖或食品补充剂。

公开(公告)号：US09410117B2

公开(公告)日：2016-08-09

申请号：US13917346

申请日：2013-06-13

Applicant: Chr. Hansen A/S

Inventor： Asger Geppel ,  Borge Windel Kringelum ,  Ken Flemming Hansen ,  Stig Lykke Iversen ,  Claus Maxel Henriksen

IPC: C12N1/20 ,  A23C9/123 ,  A23C19/032 ,  A23K1/00 ,  A23L1/03 ,  A23L3/3436 ,  A23L3/3571 ,  C12G1/022 ,  C12R1/225 ,  C12R1/46

CPC classification number: C12N1/20 ,  A23C9/123 ,  A23C19/0323 ,  A23K10/18 ,  A23L3/3436 ,  A23L3/3571 ,  A23L29/065 ,  C12G1/0203 ,  C12R1/225 ,  C12R1/46 ,  Y02E50/17

Abstract: Culturally modified lactic acid bacterial cells containing a porphyrin compound and their use in a novel method of reducing the oxygen content in a food and feed product or starting material is provided and means of improving the shelf life and/or quality of such products by using the culturally modified bacterial cells. Such culturally modified cells are useful in the manufacturing of a food and a feed product and for the manufacturing of metabolites produced by modified cells.

Abstract translation: 提供含有卟啉化合物的文化改性的乳酸菌细胞及其在减少食品和饲料产品或原料中的氧含量的新方法中的用途，以及通过使用以下方法提高这些产品的保质期和/或质量的方法： 文化修饰细菌细胞。 这种经文化修饰的细胞可用于食品和饲料产品的制造以及由改性细胞产生的代谢产物的制造。

公开(公告)号：US09326533B2

公开(公告)日：2016-05-03

申请号：US14804635

申请日：2015-07-21

Applicant: Grain Processing Corporation

Inventor： Sarjit Johal

IPC: A23K1/00 ,  A23K1/14 ,  A23K1/16 ,  A23L1/03 ,  A23L1/054 ,  A23L1/172 ,  C08L5/00 ,  C08L89/00 ,  C08L97/02 ,  C08L99/00

CPC classification number: A23K1/009 ,  A23K10/18 ,  A23K10/37 ,  A23K20/163 ,  A23L7/152 ,  A23L29/065 ,  A23L29/269 ,  A23Y2220/00 ,  A23Y2260/00 ,  A23Y2280/00 ,  A23Y2300/00 ,  A23Y2320/00 ,  C08L5/00 ,  C08L89/00 ,  C08L97/02 ,  C08L99/00 ,  Y02P60/877 ,  Y10S426/805 ,  C08L2666/26 ,  C08L2666/02

Abstract: The present invention provides a means to concentrate, dry and formulate biomaterials such as polysaccharides, gums and related biopolymers, and microorganisms such as cells, spores, and the like from dilute solutions using spent germ and other oil bearing residues. In addition, the spent germ can serve as a carrier for such biomaterials. The sorbed materials are useful in animal feeds.

公开(公告)号：US09308271B2

公开(公告)日：2016-04-12

申请号：US14129851

申请日：2012-06-30

Applicant: Birgitte Yde

Inventor： Birgitte Yde

IPC: C12N1/20 ,  A01N63/00 ,  A61K47/36 ,  A23L1/03 ,  C12N1/04 ,  A23L1/30 ,  A23L1/305 ,  A23L1/308 ,  A23L1/29 ,  A61K35/747 ,  A61K47/22

CPC classification number: A61K35/747 ,  A23L29/065 ,  A23L33/135 ,  A23L33/18 ,  A23L33/19 ,  A23L33/22 ,  A23L33/40 ,  A23V2002/00 ,  A23Y2220/03 ,  A23Y2220/15 ,  A23Y2220/17 ,  A23Y2220/23 ,  A23Y2220/29 ,  A23Y2220/31 ,  A23Y2220/35 ,  A23Y2220/39 ,  A23Y2220/49 ,  A23Y2220/73 ,  A23Y2220/79 ,  A23Y2240/75 ,  A23Y2260/00 ,  A23Y2260/25 ,  A23Y2260/35 ,  A23Y2280/00 ,  A23Y2280/55 ,  A23Y2300/21 ,  A23Y2300/49 ,  A23Y2300/55 ,  A23Y2320/00 ,  A61K47/22 ,  A61K47/36 ,  C12N1/04 ,  C12N1/20 ,  A23V2200/3204 ,  A23V2250/5062 ,  A23V2250/54246 ,  A23V2250/636

Abstract: The invention relates to a dry compositions for lactic acid bacteria and in particular to a dry composition comprising from 109 to 1013 cfu/g of the composition of lactic acid bacteria cells, wherein the composition is characterized by that it also comprises following amounts of protective agents (all amounts of protective agents below are given relative to 1 g of lactic acid bacteria cells in the composition): from 6 to 9 g of trehalose, from 0.1 to 1 g of inulin and from 0.5 to 3 g of hydrolyzed casein, and by that it does not comprise a salt of alginic acid. The composition has an improved storage stability of the cell of interest. Comparison experiments have been made between compositions with and without alginate and it has been found that there is substantially no difference between compositions with or without alginate with regard to stability. Further, the invention relates to a method for preparing a dry lactic acid bacteria composition.

Abstract translation: 本发明涉及一种用于乳酸菌的干组合物，特别涉及包含109至1013cfu / g乳酸菌细胞组合物的干组合物，其中组合物的特征还在于其还含有以下量的保护剂 （组合物中相对于1g乳酸菌细胞，所有量的保护剂）：6至9g海藻糖，0.1至1g菊粉和0.5至3g水解酪蛋白，以及 它不包含藻酸的盐。 该组合物具有改善的感兴趣的细胞的储存稳定性。 在具有和不具有藻酸盐的组合物之间进行了比较实验，并且已经发现在稳定性方面，在具有或不具有藻酸盐的组合物中基本上没有差异。 此外，本发明涉及一种制备干乳酸菌组合物的方法。

公开(公告)号：US09265276B2

公开(公告)日：2016-02-23

申请号：US13121107

申请日：2009-09-14

Applicant: Karlheinz Bortlik ,  Maurizio Beggio ,  Pierre Lambelet ,  Tuong Huynh-Ba ,  Robert Aeschbach

Inventor： Karlheinz Bortlik ,  Maurizio Beggio ,  Pierre Lambelet ,  Tuong Huynh-Ba ,  Robert Aeschbach

IPC: A61K41/00 ,  A23L1/22 ,  A23F3/40 ,  A23L1/03 ,  A23L1/30 ,  A23L2/52

CPC classification number: A23L1/22075 ,  A23F3/40 ,  A23L2/52 ,  A23L27/84 ,  A23L29/05 ,  A23L33/105 ,  A23V2002/00 ,  A23V2250/2132 ,  A23V2200/16 ,  A23V2250/1844 ,  A23V2250/1846 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/1852

Abstract: The present invention in general relates to the field of taste. In particular it relates to the reduction of astringency. One embodiment of the present invention relates to the use of at least one phospholipid for the preparation of a phenol containing composition to reduce the astringency of the composition.

Abstract translation: 本发明一般涉及味道领域。 特别是与减少涩味有关。 本发明的一个实施方案涉及至少一种磷脂用于制备含苯酚的组合物以降低组合物的涩味的用途。

公开(公告)号：US09259448B2

公开(公告)日：2016-02-16

申请号：US11815703

申请日：2006-02-06

Applicant: Guy Derrieu

Inventor： Guy Derrieu

IPC: C12N1/04 ,  A61K35/742 ,  A23L1/30 ,  A61K35/744 ,  A61K35/745 ,  A61K35/747 ,  A61K36/06 ,  A61K45/06 ,  A23L1/00 ,  A23L1/03

CPC classification number: A61K35/747 ,  A23L29/065 ,  A23L33/10 ,  A23L33/135 ,  A23L33/14 ,  A23L33/15 ,  A23L33/16 ,  A23L33/175 ,  A23P10/20 ,  A23P10/28 ,  A23V2002/00 ,  A23Y2220/67 ,  A23Y2240/00 ,  A61K9/19 ,  A61K9/20 ,  A61K35/742 ,  A61K35/744 ,  A61K35/745 ,  A61K36/06 ,  A61K45/06 ,  Y10T428/2982 ,  A61K2300/00 ,  A23V2200/254 ,  A23V2250/06 ,  A23V2250/206 ,  A23V2250/70 ,  A23V2250/76

Abstract: The invention relates to a composition comprising revivable dehydrated micro-organisms. The invention is characterized in that it further comprises particles at least 50% of which have a mean diameter greater than 250 μm. The invention is applicable, in particular, to human or veterinary pharmaceuticals, to dietetics or to food products.

Abstract translation: 本发明涉及包含可再生脱水微生物的组合物。 本发明的特征在于，其还包含至少50％的平均直径大于250μm的颗粒。 本发明特别适用于人类或兽医药品，饮食学或食品产品。

公开(公告)号：US20160038456A1

公开(公告)日：2016-02-11

申请号：US14775751

申请日：2014-03-12

Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED

Inventor： BRENT REYNOLDS ,  LOIC DELEYROLLE

IPC: A61K31/352 ,  A61K31/7028 ,  A23L1/03 ,  A61K31/26 ,  A61K45/06 ,  A61K36/31 ,  A61K31/12

CPC classification number: A61K31/352 ,  A23L29/035 ,  A23L29/055 ,  A23V2002/00 ,  A61K31/12 ,  A61K31/26 ,  A61K31/353 ,  A61K31/7028 ,  A61K36/31 ,  A61K45/06 ,  A61K2300/00

Abstract: The current invention is directed to a treatment of a proliferative disease comprising administering to a subject in need of such treatment, a composition comprising epigallocatechin-3-gallate (EGCG), curcumin, glucosinolates and, optionally Daikon radish sprout, alone or in combination with providing a ketogenic diet or a modified ketogenic diet to the subject. The invention also provides a composition comprising medium chain triglycerides, epigallocatechin-3-gallate, curcumin, compositions comprising glucosinolates and/or derivatives thereof, such as glucoraphanin and its breakdown product sulforaphane, (SFN) (which are found at high levels in broccoli sprouts or sprouts of other cruciferous vegetables), and, optionally Daikon radish sprout.

Abstract translation: 本发明涉及增殖性疾病的治疗，包括向需要这种治疗的受试者施用包含表没食子儿茶素-3-没食子酸酯（EGCG），姜黄素，硫代葡萄糖苷和任选地Daikon萝卜芽的组合物，单独或与 向受试者提供致生饮食或改良的生酮饮食。 本发明还提供一种组合物，其包含中链甘油三酯，表没食子儿茶素-3-没食子酸酯，姜黄素，包含硫代葡萄糖苷和/或其衍生物的组合物，例如葡萄糖甙元及其分解产物萝卜硫素（SFN）（其在西兰花芽中高水平发现） 或其他十字花科蔬菜的芽），以及任选的Daikon萝卜芽。

公开(公告)号：US09249403B2

公开(公告)日：2016-02-02

申请号：US14579980

申请日：2014-12-22

Applicant: DuPont Nutrition Biosciences ApS

Inventor： Ole Sibbesen ,  Jens Frisbaek Sorensen

IPC: C12N15/00 ,  C12Q1/34 ,  C07K1/00 ,  C12N9/24 ,  A23L1/03 ,  A61K38/47

CPC classification number: C12N9/2482 ,  A23L29/06 ,  A61K38/47 ,  C12N9/248 ,  C12Y302/01008

Abstract: The present invention relates to polypeptides with xylanase activity and uses thereof. The present invention also relates to method of modifying polypeptides with xylanase activity to affect, preferably to increase, xylanase activity and/or bran solubility.

Abstract translation: 本发明涉及具有木聚糖酶活性的多肽及其用途。 本发明还涉及用木聚糖酶活性修饰多肽以影响，优选增加木聚糖酶活性和/或麸皮溶解度的方法。

公开(公告)号：US09180148B2

公开(公告)日：2015-11-10

申请号：US13932494

申请日：2013-07-01

Applicant: Naidu LP

Inventor： A. Satyanarayan Naidu ,  A. G. Tezus Naidu ,  A. G. Sreus Naidu

IPC: A61K38/40 ,  A61K38/43 ,  A61K35/745 ,  A23L1/03 ,  A23L1/29 ,  A23L1/30 ,  A23L1/302 ,  A23L1/304 ,  A23L1/305 ,  A23L1/308 ,  A61K9/00 ,  A61K9/16 ,  A61K31/715 ,  A61K31/718 ,  A61K31/737 ,  A61K36/185 ,  A61K36/27 ,  A61K36/48 ,  A61K36/54 ,  A61K36/55 ,  A61K36/68 ,  A61K38/44 ,  A61K38/47 ,  A61K45/06 ,  A61K35/747

CPC classification number: A61K35/745 ,  A23L29/06 ,  A23L33/105 ,  A23L33/115 ,  A23L33/135 ,  A23L33/15 ,  A23L33/16 ,  A23L33/17 ,  A23L33/175 ,  A23L33/19 ,  A23L33/21 ,  A23L33/30 ,  A23V2002/00 ,  A61K9/0095 ,  A61K9/1617 ,  A61K31/715 ,  A61K31/718 ,  A61K31/737 ,  A61K35/747 ,  A61K36/185 ,  A61K36/27 ,  A61K36/48 ,  A61K36/54 ,  A61K36/55 ,  A61K36/68 ,  A61K38/40 ,  A61K38/44 ,  A61K38/446 ,  A61K38/47 ,  A61K45/06 ,  A61K2300/00 ,  A23V2200/30 ,  A23V2200/332 ,  A23V2250/54248

Abstract: Formulations are provided for the management of weight. The formulations generally include a trigger complex, an elemental complex and a coenzyme-vitamin B complex. The trigger complex is high in fiber such as glucomannan and includes Metallo-Lactoferrin protein in an alkaline buffer system. The elemental complex includes one or more trace element as a suitable salt. The coenzyme-vitamin B complex includes one or more coenzyme, coenzyme precursor and/or B-vitamin. The compositions may optionally include additional components such as dihydroxy acetone (DHA), inositol, 5-hydroxy-L-tryptophan (5-HTP), choline, milk protein hydrolysate, and pyruvate. The compositions can be administered orally in a variety of forms and may substitute for one or more meals per day to manage weight.

Abstract translation: 提供配方用于管理体重。 制剂通常包括触发复合物，元素复合物和辅酶维生素B复合物。 触发复合物在纤维如葡甘露聚糖中是高的，并且在碱性缓冲系统中包括金属 - 乳铁蛋白。 元素络合物包括一种或多种作为合适盐的微量元素。 辅酶维生素B复合物包括一种或多种辅酶，辅酶前体和/或β-维生素。 组合物可以任选地包括另外的组分，例如二羟基丙酮（DHA），肌醇，5-羟基-L-色氨酸（5-HTP），胆碱，乳蛋白水解产物和丙酮酸盐。 组合物可以以各种形式口服给药，并且可以每天代替一次或多次膳食来治疗体重。